Recommended videos you might also like
11:20
Barostim Neuromodulation and Quality of Life: Real World Experience
04:58
Quantifying Preference Values for Non-metastatic Castration-resistant Prostat...
03:14
Jara Herron on Her Experience as Cardiogenic Shock Patient Treated with an Im...
16:52
ESMO GI/DiCE Symposium 2020 Session 1: The Value of Patient Organisations
04:53
ESMO GI/DiCE Symposium 2020, Session II: Driving the Research to Meet Patient...
24:52
Managing Acute Respiratory Distress Syndrome (ARDS) in COVID-19.
EORTC - Understanding Cancer
5 views
Uploaded on Oct 30, 2020
European Organisation for Research and Treatment of Cancer (EORTC)
2 videos
Join the conversation
to comment
Related videos
European Organisation for Research and Treatment of Cancer (EORTC)
EORTC - The future of cancer therapy
Bayer
Preference Values in Treatment of Non-metastatic Castration-Resistant prostate Cancer for HTA - The Patient Perspective
Bayer
Preference Values in Treatment of Non-metastatic Castration-Resistant prostate Cancer for HTA - The Physician Perspective
OPCI
